Demuth D - Search Results

1

Efficacy and safety of vedolizumab in Crohn's disease in patients from Asian countries in the GEMINI 2 study.

Banerjee R, Chuah SW, Hilmi IN, Wu DC, Yang SK, Demuth D, Lindner D, Adsul S. Banerjee R, et al. Among authors: demuth d. Intest Res. 2021 Jan;19(1):83-94. doi: 10.5217/ir.2019.09160. Epub 2020 Dec 31. Intest Res. 2021. PMID: 33378612 Free PMC article.

2

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study.

Ooi CJ, Hilmi IN, Kim HJ, Jalihal U, Wu DC, Demuth D, Lindner D, Adsul S. Ooi CJ, et al. Among authors: demuth d. Intest Res. 2021 Jan;19(1):71-82. doi: 10.5217/ir.2019.09159. Epub 2020 Sep 4. Intest Res. 2021. PMID: 32877600 Free PMC article.

3

Early Intervention With Vedolizumab on Longer Term Surgery Rates in Crohn's Disease: Post Hoc Analysis of the GEMINI Phase 3 and Long-term Safety Programs.

Dulai PS, Peyrin-Biroulet L, Demuth D, Lasch K, Hahn KA, Lindner D, Patel H, Jairath V. Dulai PS, et al. Among authors: demuth d. J Crohns Colitis. 2020 Jul 21;15(2):195-202. doi: 10.1093/ecco-jcc/jjaa153. Online ahead of print. J Crohns Colitis. 2020. PMID: 32691844 Free PMC article.

4

A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK: The REVIVE study.

Cummings F, Gaya DR, Levison S, Subramanian S, Owen G, Rathmell A, Glen F, Demuth D, Meadowcroft S, Irving PM. Cummings F, et al. Among authors: demuth d. Medicine (Baltimore). 2019 Mar;98(9):e14681. doi: 10.1097/MD.0000000000014681. Medicine (Baltimore). 2019. PMID: 30817598 Free PMC article.

5

Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study.

Yamamoto-Furusho JK, Al Harbi O, Armuzzi A, Chan W, Ponce de Leon E, Qian J, Shapina M, Toruner M, Tu CH, Ye BD, Guennec M, Sison C, Demuth D, Fadeeva O, Khan QMR. Yamamoto-Furusho JK, et al. Among authors: demuth d. Dig Liver Dis. 2020 Aug;52(8):869-877. doi: 10.1016/j.dld.2020.05.031. Epub 2020 Jun 17. Dig Liver Dis. 2020. PMID: 32563721 Free article.

6

Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease.

Schreiber S, Dignass A, Peyrin-Biroulet L, Hather G, Demuth D, Mosli M, Curtis R, Khalid JM, Loftus EV Jr. Schreiber S, et al. Among authors: demuth d. J Gastroenterol. 2018 Sep;53(9):1048-1064. doi: 10.1007/s00535-018-1480-0. Epub 2018 Jun 4. J Gastroenterol. 2018. PMID: 29869016 Free PMC article.

7

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.

Bressler B, Yarur A, Silverberg MS, Bassel M, Bellaguarda E, Fourment C, Gatopoulou A, Karatzas P, Kopylov U, Michalopoulos G, Michopoulos S, Navaneethan U, Rubin DT, Siffledeen J, Singh A, Soufleris K, Stein D, Demuth D, Mantzaris GJ. Bressler B, et al. Among authors: demuth d. J Crohns Colitis. 2021 Oct 7;15(10):1694-1706. doi: 10.1093/ecco-jcc/jjab058. J Crohns Colitis. 2021. PMID: 33786600 Free PMC article.

8

Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study.

Li J, Liu Z, Hu P, Wen Z, Cao Q, Zou X, Chen Y, Wang Y, Zhong J, Shen X, Demuth D, Fadeeva O, Xie L, Chen J, Qian J. Li J, et al. Among authors: demuth d. BMC Gastroenterol. 2022 Feb 4;22(1):44. doi: 10.1186/s12876-021-02074-z. BMC Gastroenterol. 2022. PMID: 35120446 Free PMC article.

9

Reasons for nonuse of antiviral treatment in patients with chronic hepatitis C infection and thrombocytopaenia: a retrospective chart review from five European countries.

Rizzetto M, Grotzinger K, Theodore D, Demuth D, Irving WL, Manns M, Roughley A, Forssen UM. Rizzetto M, et al. Among authors: demuth d. J Viral Hepat. 2014 Oct;21(10):e129-34. doi: 10.1111/jvh.12256. Epub 2014 Apr 3. J Viral Hepat. 2014. PMID: 24698004

10

Severity of liver disease among chronic hepatitis C patients: an observational study of 4594 patients in five European countries.

Marcellin P, Grotzinger K, Theodore D, Demuth D, Manns M, Bañares Cañizares R, Pike J, Forssen UM. Marcellin P, et al. Among authors: demuth d. J Gastroenterol Hepatol. 2015 Feb;30(2):364-71. doi: 10.1111/jgh.12698. J Gastroenterol Hepatol. 2015. PMID: 25088088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters